Schizotypal Personality Disorder
📧 Sign up to get email alerts when something new happens for Schizotypal Personality Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Effect of Immersive Virtual Reality-based Cognitive Remediation in Patients With Mood - or Psychosis Spectrum Disorders [NA]
A completed clinical trial assessing immersive virtual reality–based cognitive remediation for mood- and psychosis-spectrum disorders.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: A D1 Agonist For Working Memory [Phase 2]
Phase 2 trial update reporting completion of a study evaluating a D1 dopamine receptor agonist for working memory in individuals with Schizo…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Exceptional Experiences (EE), Salience & Dopaminergic Neurotransmission [EARLY_Phase 1]
An early-phase 1 trial completed at the University of Zurich exploring exceptional experiences, salience, and dopaminergic neurotransmission…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Schizotypal Personality Disorder Risperidone [Phase 1, Phase 2]
Phase 1 and Phase 2 studies evaluating risperidone for schizotypal personality disorder have been completed.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: CRT-Guanfacine for SPD [Phase 2]
A Phase 2 trial investigating CRT-Guanfacine for Schizotypal Personality Disorder has completed; the update does not include results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Pharmacology of Cognition in Schizotypal Personality Disorder [Phase 4]
Phase 4 clinical trial evaluating pharmacology of cognition in schizotypal personality disorder has been terminated; sponsor is Icahn School…